Pfizer to Acquire Small Molecule Anti-Infective Business from AstraZeneca
Go back to Pfizer to Acquire Small Molecule Anti-Infective Business from AstraZeneca| Pfizer Inc. (NYSE: PFE) | Delayed: 25.21 -0.71 (2.74%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $25.92 | 52 Week High | $37.39 | |||
| Open | $25.58 | 52 Week Low | $28.25 | |||
| Day High | $25.36 | P/E | 15.28 | |||
| Day Low | $24.94 | EPS | $1.65 | |||
| Volume | 119,614,341 | |||||
| Sumitomo Chemical Co Ltd Unsponsored ADR (AMEX: SOMMY) | Delayed: 17.38 -0.13 (0.74%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $17.51 | 52 Week High | $30.01 | |||
| Open | $17.38 | 52 Week Low | $19.54 | |||
| Day High | $17.38 | P/E | N/A | |||
| Day Low | $17.38 | EPS | $0.00 | |||
| Volume | 347 | |||||
